Oncomine Lung cfTNA Cancer Panel Test sale cost 10500 AED
Genome Signature HRD Test sale cost 54000 AED Genome Signature HRD Test Cost 72,000 د.إ Original price was: 72,000 د.إ.54,000 د.إCurrent price is: 54,000 د.إ.
Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test sale cost 9010 AED Glucose-6-Phosphate Dehydrogenase G6PD Full-Length Gene Sequence Analysis Test Cost 10,010 د.إ Original price was: 10,010 د.إ.9,010 د.إCurrent price is: 9,010 د.إ.
Sale!

Oncomine Lung cfTNA Cancer Panel Test Cost

Original price was: 14,000 د.إ.Current price is: 10,500 د.إ.

-25%

The Oncomine Lung cfTNA Cancer Panel Test, available at DNA Labs UAE for a cost of 10,500 AED, is a highly advanced diagnostic tool designed for the detection and analysis of circulating free tumor nucleic acids (cfTNA) in the blood of patients suspected to have lung cancer. This non-invasive test utilizes next-generation sequencing (NGS) technology to identify genetic mutations and alterations in cfTNA that are associated with lung cancer. By analyzing a simple blood sample, the test can provide critical information on the genetic makeup of lung tumors, aiding clinicians in making more informed decisions regarding treatment strategies. This approach not only offers a convenient alternative to traditional tissue biopsies but also enables the monitoring of tumor dynamics and resistance mechanisms over time. DNA Labs UAE, by offering this cutting-edge test, demonstrates its commitment to providing state-of-the-art diagnostic solutions to improve patient care and outcomes in the fight against lung cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Oncomine Lung cfTNA Cancer Panel Test

At DNA Labs UAE, we offer the Oncomine Lung cfTNA Cancer Panel Test for patients with non-small cell lung cancer (NSCLC). This next-generation sequencing (NGS) panel detects mutations in cell-free tumor DNA (cfTNA) in the blood, providing valuable information for diagnosis and treatment.

Test Details

The Oncomine Lung cfTNA Cancer Panel Test targets 11 genes commonly mutated in NSCLC, including EGFR, KRAS, BRAF, ALK, ROS1, MET, RET, HER2, PIK3CA, TP53, and STK11. This comprehensive panel is designed to detect low-frequency mutations with high sensitivity, enabling early detection of cancer recurrence and monitoring of treatment response.

Components

  • Streak Tube

Price

The cost of the Oncomine Lung cfTNA Cancer Panel Test is 10500.0 AED.

Sample Condition

We require a peripheral blood sample of 10 ml for the test.

Report Delivery

Once the sample is received, the report will be delivered within 2-3 weeks.

Method

The Oncomine Lung cfTNA Cancer Panel Test utilizes next-generation sequencing (NGS) technology for accurate and efficient analysis.

Test Type

The Oncomine Lung cfTNA Cancer Panel Test falls under the category of genetics testing.

Doctor

A general physician can request the Oncomine Lung cfTNA Cancer Panel Test for their patients.

Test Department

The Oncomine Lung cfTNA Cancer Panel Test is conducted in our Genetics Test Department.

Pre Test Information

The Oncomine Lung cfTNA Cancer Panel Test requires a doctor’s prescription. However, please note that the test is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.

Benefits

The Oncomine Lung cfTNA Cancer Panel Test offers a non-invasive alternative to traditional tissue biopsies, making it suitable for patients who are unable to undergo biopsy or for whom biopsy results are inconclusive. This test provides valuable information for accurate diagnosis and personalized treatment plans.

Conclusion

The Oncomine Lung cfTNA Cancer Panel Test offered by DNA Labs UAE is a highly sensitive and efficient method for detecting mutations in cell-free tumor DNA in patients with non-small cell lung cancer. With its comprehensive gene coverage and ability to detect low-frequency mutations, this test allows for early detection of cancer recurrence and monitoring of treatment response. Contact us today to learn more about this test and how it can benefit your patients.

Test Name Oncomine Lung cfTNA Cancer Panel Test
Components Streak Tube
Price 10500.0 AED
Sample Condition Peripheral blood (10 ml.)
Report Delivery 2-3 weeks
Method NGS
Test type Genetics
Doctor General Physician
Test Department:
Pre Test Information Oncomine LungcfTNA Cancer Panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Oncomine Lung cfTNA Cancer Panel is a next-generation sequencing (NGS) panel that detects mutations in cell-free tumor DNA (cfTNA) in the blood of patients with non-small cell lung cancer (NSCLC). The panel targets 11 genes that are commonly mutated in NSCLC, including EGFR, KRAS, BRAF, ALK, ROS1, MET, RET, HER2, PIK3CA, TP53, and STK11. The panel is designed to detect low-frequency mutations with high sensitivity, allowing for early detection of cancer recurrence and monitoring of treatment response. The Oncomine Lung cfTNA Cancer Panel is a non-invasive alternative to traditional tissue biopsies, making it a valuable tool for patients who are unable to undergo biopsy or for whom biopsy results are inconclusive.

SKU: TEST-689 Category:

Related products